A Trial Investigating the Pharmacodynamic Response of NN5401 in Subjects With Type 2 Diabetes.
Phase of Trial: Phase I
Latest Information Update: 26 Nov 2013
At a glance
- Drugs Insulin aspart/insulin protamine aspart; Insulin degludec/insulin aspart
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 25 Nov 2010 Status changed from active, no longer recruiting to completed.
- 10 Sep 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 25 Aug 2010 Planned end date changed from 1 Oct 2010 to 1 Nov 2010 as reported by ClinicalTrials.gov.